Area of research
Molecular Biology · Surgery
Research interest
Research interests include Pluripotent Stem Cells Research, Angiogenesis and VEGF in Cancer, Histone Deacetylase Inhibitors Research, and Tissue Engineering and Regenerative Medicine.
Unveiling impaired vascular function and cellular heterogeneity in diabetic donor-derived vascular organoids
Human blood vessel organoids reveal a critical role for CTGF in maintaining microvascular integrity
Targeting QKI-7 in vivo restores endothelial cell function in diabetes
The RNA-binding protein QKI controls alternative splicing in vascular cells, producing an effective model for therapy
Enhanced Function of Induced Pluripotent Stem Cell-Derived Endothelial Cells Through ESM1 Signaling
Quaking Is a Key Regulator of Endothelial Cell Differentiation, Neovascularization, and Angiogenesis
Transdifferentiated Human Vascular Smooth Muscle Cells are a New Potential Cell Source for Endothelial Regeneration
XBP 1-Deficiency Abrogates Neointimal Lesion of Injured Vessels Via Cross Talk With the PDGF Signaling
c-Kit+ progenitors generate vascular cells for tissue-engineered grafts through modulation of the Wnt/Klf4 pathway
Unspliced X-box-binding Protein 1 (XBP1) Protects Endothelial Cells from Oxidative Stress through Interaction with Histone Deacetylase 3
MicroRNA-199b Modulates Vascular Cell Fate During iPS Cell Differentiation by Targeting the Notch Ligand Jagged1 and Enhancing VEGF Signaling
Dysfunction of Endothelial Progenitor Cells from Smokers and Chronic Obstructive Pulmonary Disease Patients Due to Increased DNA Damage and Senescence
Histone Deacetylase 3 Unconventional Splicing Mediates Endothelial-to-mesenchymal Transition through Transforming Growth Factor β2
XBP1 mRNA Splicing Triggers an Autophagic Response in Endothelial Cells through BECLIN-1 Transcriptional Activation
Direct reprogramming of fibroblasts into endothelial cells capable of angiogenesis and reendothelialization in tissue-engineered vessels